Promacta (eltrombopag) - Novartis
CCPO011: Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors (clinicaltrials.gov) - Oct 10, 2026 - P1 | N=9 | Terminated | Sponsor: University of California, Davis | Suspended ➔ Terminated; PI discretion; suspended while CAPA is reviewed 
Trial termination • Hepatocellular Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT04485416
 
Oct 10, 2026
 
Prev Next